Skip to main content
Top
Published in: Inflammation 1/2018

01-02-2018 | ORIGINAL ARTICLE

Establishment of S100A8 Transgenic Rats to Understand Innate Property of S100A8 and Its Immunological Role

Authors: Kohki Okada, Hiroshi Itoh, Yasuhiko Kamikubo, Souichi Adachi, Masaki Ikemoto

Published in: Inflammation | Issue 1/2018

Login to get access

Abstract

The innate properties of S100A8 as a regulator in acute inflammation have not yet been elucidated in detail. Our aims are to newly establish S100A8 transgenic rats (Tg-S100A8) and to elucidate the immunological functions of S100A8. Following the treatment with 5% dextran sulfate sodium for 1 week, the body weight in Tg-S100A8 weakly decreased after the start; however, that in Japanese Wistar rats (WT) significantly decreased in the end. The serum level of CRP in Tg-S100A8 was significantly lower than that in WT, although the concentration of CRP apparently increased in both Tg-S100A8 and WT. The dynamic mobility of S100A8 and S100A9 in macrophages was microscopically observed using fluorescent immunological staining, in which the S100A9 was dominantly expressed in many macrophages in the rectal tissue of WT. As determined by PCR and real-time PCR, the levels of S100A8 messenger RNA (mRNA) in several organ tissues of the Tg-S100A8, such as heart and small intestine, were apparently higher than those of WT, respectively. The expression of IL-6 and TNF-α mRNAs was negatively regulated in main organ tissues of the large colon of Tg-S100A8 followed by down-regulation of IL-6 protein. An important result was that the expression of S100A8 mRNA was strongly induced in many macrophages of Tg-S100A8, whereas that of some inflammatory cytokine mRNAs described above were significantly reduced. Tg-S100A8 has potential as a useful experimental model rat not only for investigating the innate properties of S100A8 as a regulator, but also for clarifying its functional role in immune cells from a myeloid origin, particularly macrophages.
Literature
1.
go back to reference Odink, K., N. Gerletti, J. Bruggen, R.G. Clerc, L. Tarcsay, G. Zwadlo, G. Gerhards, R. Schlegel, and C. Sorg. 1987. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80–82.CrossRefPubMed Odink, K., N. Gerletti, J. Bruggen, R.G. Clerc, L. Tarcsay, G. Zwadlo, G. Gerhards, R. Schlegel, and C. Sorg. 1987. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80–82.CrossRefPubMed
2.
go back to reference Nacken, W., J. Roth, C. Sorg, and C. Kerkhoff. 2003. S100A9/S100A8: myeloid representatives of the S100: protein family as prominent players in innate immunity. Microscopy Research and Technique 60: 569–580.CrossRefPubMed Nacken, W., J. Roth, C. Sorg, and C. Kerkhoff. 2003. S100A9/S100A8: myeloid representatives of the S100: protein family as prominent players in innate immunity. Microscopy Research and Technique 60: 569–580.CrossRefPubMed
3.
go back to reference Ryckman, C., K. Vandal, P. Rouleau, M. Talbot, and P.A. Tessier. 2003. Proinflammatory activities of S100 proteins: S100A8, S100A9, And S100A8/A9 induce neutrophil chemotaxis and adhesion. The Journal of Immunology 170: 3233–3242.CrossRefPubMed Ryckman, C., K. Vandal, P. Rouleau, M. Talbot, and P.A. Tessier. 2003. Proinflammatory activities of S100 proteins: S100A8, S100A9, And S100A8/A9 induce neutrophil chemotaxis and adhesion. The Journal of Immunology 170: 3233–3242.CrossRefPubMed
4.
go back to reference Kane, D., J. Roth, M. Frosch, T. Vogl, B. Bresnihan, and O. FitzGerald. 2003. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis & Rheumatology 48: 1676–1685.CrossRef Kane, D., J. Roth, M. Frosch, T. Vogl, B. Bresnihan, and O. FitzGerald. 2003. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis & Rheumatology 48: 1676–1685.CrossRef
5.
go back to reference Hammer, H.B., S. Odegard, M.K. Fagerhol, R. Landewé, D. van der Heijde, T. Uhlig, P. Mowinckel, and T.K. Kvien. 2007. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Annals of the Rheumatic Diseases 66: 1093–1097.CrossRefPubMedPubMedCentral Hammer, H.B., S. Odegard, M.K. Fagerhol, R. Landewé, D. van der Heijde, T. Uhlig, P. Mowinckel, and T.K. Kvien. 2007. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Annals of the Rheumatic Diseases 66: 1093–1097.CrossRefPubMedPubMedCentral
6.
go back to reference Marionnet, C., F. Bernerd, A. Dumas, F. Verrecchia, K. Mollier, D. Compan, B. Bernard, M. Lahfa, J. Leclaire, C. Medaisko, B. Mehul, S. Seité, A. Mauviel, and L. Dubertret. 2003. Modulation of gene expression induced in human epidermis by environmental stress in vivo. Journal of Investigative Dermatology 121: 1447–1458.CrossRefPubMed Marionnet, C., F. Bernerd, A. Dumas, F. Verrecchia, K. Mollier, D. Compan, B. Bernard, M. Lahfa, J. Leclaire, C. Medaisko, B. Mehul, S. Seité, A. Mauviel, and L. Dubertret. 2003. Modulation of gene expression induced in human epidermis by environmental stress in vivo. Journal of Investigative Dermatology 121: 1447–1458.CrossRefPubMed
7.
go back to reference Benoit, S., A. Toksoy, M. Ahlmann, M. Schmidt, C. Sunderkötter, D. Foell, M. Pasparakis, J. Roth, and M. Goebeler. 2006. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. British Journal of Dermatology 155: 62–66.CrossRefPubMed Benoit, S., A. Toksoy, M. Ahlmann, M. Schmidt, C. Sunderkötter, D. Foell, M. Pasparakis, J. Roth, and M. Goebeler. 2006. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. British Journal of Dermatology 155: 62–66.CrossRefPubMed
8.
go back to reference Foell, D., H. Wittkowski, Z. Ren, J. Turton, G. Pang, J. Daebritz, J. Ehrchen, J. Heidemann, T. Borody, J. Roth, and R. Clancy. 2008. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. The Journal of Pathology 216: 183–192.CrossRefPubMed Foell, D., H. Wittkowski, Z. Ren, J. Turton, G. Pang, J. Daebritz, J. Ehrchen, J. Heidemann, T. Borody, J. Roth, and R. Clancy. 2008. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. The Journal of Pathology 216: 183–192.CrossRefPubMed
9.
10.
go back to reference Guignard, F., J. Mauel, and M. Markert. 1995. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochemical Journal 309: 395–401.CrossRefPubMedPubMedCentral Guignard, F., J. Mauel, and M. Markert. 1995. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochemical Journal 309: 395–401.CrossRefPubMedPubMedCentral
11.
go back to reference Kaisho, T., and S. Akira. 2001. Toll-like receptors and their signaling mechanism in innate immunity. Acta Odontologica Scandinavica 59: 124–130.CrossRefPubMed Kaisho, T., and S. Akira. 2001. Toll-like receptors and their signaling mechanism in innate immunity. Acta Odontologica Scandinavica 59: 124–130.CrossRefPubMed
12.
go back to reference Li, Q., and B.J. Cherayil. 2003. Role of toll-like receptor 4 in macrophage activation and tolerance during salmonella enterica serovar typhimurium infection. Infection and Immunity 71: 4873–4882.CrossRefPubMedPubMedCentral Li, Q., and B.J. Cherayil. 2003. Role of toll-like receptor 4 in macrophage activation and tolerance during salmonella enterica serovar typhimurium infection. Infection and Immunity 71: 4873–4882.CrossRefPubMedPubMedCentral
13.
go back to reference Chen, X., L. Zhang, I.Y. Zhang, J. Liang, H. Wang, M. Ouyang, S. Wu, A.C. da Fonseca, L. Weng, Y. Yamamoto, H. Yamamoto, R. Natarajan, and B. Badie. 2014. RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma. Cancer Research 74: 7285–7297.CrossRefPubMedPubMedCentral Chen, X., L. Zhang, I.Y. Zhang, J. Liang, H. Wang, M. Ouyang, S. Wu, A.C. da Fonseca, L. Weng, Y. Yamamoto, H. Yamamoto, R. Natarajan, and B. Badie. 2014. RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma. Cancer Research 74: 7285–7297.CrossRefPubMedPubMedCentral
14.
go back to reference Friggeri, A., S. Banerjee, S. Biswas, A. de Freitas, G. Liu, A. Bierhaus, and E. Abraham. 2011. Participation of the receptor for advanced glycation end products in efferocytosis. The Journal of Immunology 186: 6191–6198.CrossRefPubMedPubMedCentral Friggeri, A., S. Banerjee, S. Biswas, A. de Freitas, G. Liu, A. Bierhaus, and E. Abraham. 2011. Participation of the receptor for advanced glycation end products in efferocytosis. The Journal of Immunology 186: 6191–6198.CrossRefPubMedPubMedCentral
15.
go back to reference Németh, J., I. Stein, D. Haag, A. Riehl, T. Longerich, E. Horwitz, K. Breuhahn, C. Gebhardt, P. Schirmacher, M. Hahn, Y. Ben-Neriah, E. Pikarsky, P. Angel, and J. Hess. 2009. S100A8 And S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 50: 1251–1262.CrossRefPubMed Németh, J., I. Stein, D. Haag, A. Riehl, T. Longerich, E. Horwitz, K. Breuhahn, C. Gebhardt, P. Schirmacher, M. Hahn, Y. Ben-Neriah, E. Pikarsky, P. Angel, and J. Hess. 2009. S100A8 And S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 50: 1251–1262.CrossRefPubMed
16.
go back to reference Kwon, C.H., H.J. Moon, H.J. Park, J.H. Choi, and D.Y. Park. 2013. S100A8 And S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells. Molecules and Cells 35: 226–234.CrossRefPubMedPubMedCentral Kwon, C.H., H.J. Moon, H.J. Park, J.H. Choi, and D.Y. Park. 2013. S100A8 And S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells. Molecules and Cells 35: 226–234.CrossRefPubMedPubMedCentral
17.
go back to reference Ikemoto, M., H. Murayama, H. Itoh, M. Totani, and M. Fujita. 2007. Intrinsic function of S100A8/A9 complex as an anti-inflammatory protein in liver injury induced by lipopolysaccharide in rats. Clinica Chimica Acta 376: 197–204.CrossRef Ikemoto, M., H. Murayama, H. Itoh, M. Totani, and M. Fujita. 2007. Intrinsic function of S100A8/A9 complex as an anti-inflammatory protein in liver injury induced by lipopolysaccharide in rats. Clinica Chimica Acta 376: 197–204.CrossRef
18.
go back to reference Otsuka, K., F. Terasaki, M. Ikemoto, S. Fujita, B. Tsukada, T. Katashima, Y. Kanzaki, K. Sohmiya, T. Kono, H. Toko, M. Fujita, and Y. Kitaura. 2009. Suppression of inflammation in rat autoimmune myocarditis by S100A8/A9 through modulation of the proinflammatory cytokine network. European Journal of Heart Failure 11: 229–237.CrossRefPubMedPubMedCentral Otsuka, K., F. Terasaki, M. Ikemoto, S. Fujita, B. Tsukada, T. Katashima, Y. Kanzaki, K. Sohmiya, T. Kono, H. Toko, M. Fujita, and Y. Kitaura. 2009. Suppression of inflammation in rat autoimmune myocarditis by S100A8/A9 through modulation of the proinflammatory cytokine network. European Journal of Heart Failure 11: 229–237.CrossRefPubMedPubMedCentral
19.
go back to reference Okada, K., S. Arai, H. Nakase, H. Kohno, F. Nakamura, M. Takeda, Y. Toda, H. Itoh, S. Adachi, and M. Ikemoto. 2015. Autocrine pathways involving S100A8 and/or S100A9 that are postulated to regulate the immunological functions of macrophages in rats. Biochemical and Biophysical Research Communications 456: 415–420.CrossRefPubMed Okada, K., S. Arai, H. Nakase, H. Kohno, F. Nakamura, M. Takeda, Y. Toda, H. Itoh, S. Adachi, and M. Ikemoto. 2015. Autocrine pathways involving S100A8 and/or S100A9 that are postulated to regulate the immunological functions of macrophages in rats. Biochemical and Biophysical Research Communications 456: 415–420.CrossRefPubMed
20.
go back to reference Okada, K., S. Arai, H. Itoh, S. Adachi, M. Hayashida, H. Nakase, and M. Ikemoto. 2016. CD68 On rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions. Journal of Leukocyte Biology 100: 1093–1104.CrossRefPubMed Okada, K., S. Arai, H. Itoh, S. Adachi, M. Hayashida, H. Nakase, and M. Ikemoto. 2016. CD68 On rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions. Journal of Leukocyte Biology 100: 1093–1104.CrossRefPubMed
21.
22.
go back to reference Watanabe, T., A. Kitani, P.J. Murray, and W. Strober. 2004. NOD2 Is a negative regulator of toll-like receptor 2-mediated T helper type 1 responses. Nature Immunology 5: 800–808.CrossRefPubMed Watanabe, T., A. Kitani, P.J. Murray, and W. Strober. 2004. NOD2 Is a negative regulator of toll-like receptor 2-mediated T helper type 1 responses. Nature Immunology 5: 800–808.CrossRefPubMed
23.
go back to reference Rufini, S., C. Ciccacci, D. Di Fusco, A. Ruffa, F. Pallone, G. Novelli, L. Biancone, and P. Borgiani. 2015. Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn’s disease. Digestive and Liver Disease 47: 744–750.CrossRefPubMed Rufini, S., C. Ciccacci, D. Di Fusco, A. Ruffa, F. Pallone, G. Novelli, L. Biancone, and P. Borgiani. 2015. Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn’s disease. Digestive and Liver Disease 47: 744–750.CrossRefPubMed
24.
go back to reference Salem, M., M. Ammitzboell, K. Nys, J.B. Seidelin, and O.H. Nielsen. 2015. ATG16L1: A multifunctional susceptibility factor in Crohn disease. Autophagy 11: 585–594.CrossRefPubMedPubMedCentral Salem, M., M. Ammitzboell, K. Nys, J.B. Seidelin, and O.H. Nielsen. 2015. ATG16L1: A multifunctional susceptibility factor in Crohn disease. Autophagy 11: 585–594.CrossRefPubMedPubMedCentral
25.
go back to reference Kucharzik, T., C. Maaser, A. Lügering, M. Kagnoff, L. Mayer, S. Targan, and W. Domschke. 2006. Recent understanding of IBD pathogenesis: Implications for future therapies. Inflammatory Bowel Diseases 12: 1068–1083.CrossRefPubMed Kucharzik, T., C. Maaser, A. Lügering, M. Kagnoff, L. Mayer, S. Targan, and W. Domschke. 2006. Recent understanding of IBD pathogenesis: Implications for future therapies. Inflammatory Bowel Diseases 12: 1068–1083.CrossRefPubMed
26.
go back to reference Lissner, D., M. Schumann, A. Batra, L.I. Kredel, A.A. Kühl, U. Erben, C. May, J.D. Schulzke, and B. Siegmund. 2015. Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD. Inflammatory Bowel Diseases 21: 1297–1305.PubMedPubMedCentral Lissner, D., M. Schumann, A. Batra, L.I. Kredel, A.A. Kühl, U. Erben, C. May, J.D. Schulzke, and B. Siegmund. 2015. Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD. Inflammatory Bowel Diseases 21: 1297–1305.PubMedPubMedCentral
27.
go back to reference Lee, M.J., J.K. Lee, J.W. Choi, C.S. Lee, J.H. Sim, C.H. Cho, K.H. Lee, I.H. Cho, M.H. Chung, H.R. Kim, and S.K. Ye. 2012. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PloS One 7: e38801.CrossRefPubMedPubMedCentral Lee, M.J., J.K. Lee, J.W. Choi, C.S. Lee, J.H. Sim, C.H. Cho, K.H. Lee, I.H. Cho, M.H. Chung, H.R. Kim, and S.K. Ye. 2012. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PloS One 7: e38801.CrossRefPubMedPubMedCentral
28.
go back to reference Yoshino, T., H. Nakase, Y. Honzawa, K. Matsumura, S. Yamamoto, Y. Takeda, S. Ueno, N. Uza, S. Masuda, K. Inui, and T. Chiba. 2010. Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis. Inflammatory Bowel Diseases 16: 2022–2033.CrossRefPubMed Yoshino, T., H. Nakase, Y. Honzawa, K. Matsumura, S. Yamamoto, Y. Takeda, S. Ueno, N. Uza, S. Masuda, K. Inui, and T. Chiba. 2010. Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis. Inflammatory Bowel Diseases 16: 2022–2033.CrossRefPubMed
29.
go back to reference Okabe, M., M. Ikawa, K. Kominami, T. Nakanishi, and Y. Nishimune. 1997. Green mice' as a source of ubiquitous green cells. FEBS Letters 407: 313–319.CrossRefPubMed Okabe, M., M. Ikawa, K. Kominami, T. Nakanishi, and Y. Nishimune. 1997. Green mice' as a source of ubiquitous green cells. FEBS Letters 407: 313–319.CrossRefPubMed
30.
go back to reference Rutz, S., N. Kayagaki, Q.T. Phung, C. Eidenschenk, R. Noubade, X. Wang, J. Lesch, R. Lu, K. Newton, O.W. Huang, A.G. Cochran, M. Vasser, B.P. Fauber, J. DeVoss, J. Webster, L. Diehl, Z. Modrusan, D.S. Kirkpatrick, J.R. Lill, W. Ouyang, and V.M. Dixit. 2015. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature 518: 417–421.CrossRefPubMed Rutz, S., N. Kayagaki, Q.T. Phung, C. Eidenschenk, R. Noubade, X. Wang, J. Lesch, R. Lu, K. Newton, O.W. Huang, A.G. Cochran, M. Vasser, B.P. Fauber, J. DeVoss, J. Webster, L. Diehl, Z. Modrusan, D.S. Kirkpatrick, J.R. Lill, W. Ouyang, and V.M. Dixit. 2015. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature 518: 417–421.CrossRefPubMed
31.
go back to reference Ikemoto, M., T. Tanaka, Y. Takai, H. Murayama, K. Tanaka, and M. Fujita. 2003. New ELISA system for myeloid-related protein complex (MRP8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clinical Chemistry 49: 594–600.CrossRefPubMed Ikemoto, M., T. Tanaka, Y. Takai, H. Murayama, K. Tanaka, and M. Fujita. 2003. New ELISA system for myeloid-related protein complex (MRP8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clinical Chemistry 49: 594–600.CrossRefPubMed
32.
go back to reference Koike, A., S. Arai, S. Yamada, A. Nagae, N. Saita, H. Itoh, S. Uemoto, M. Totani, and M. Ikemoto. 2012. Dynamic mobility of immunological cells expressing S100A8 and S100A9 in vivo: A variety of functional roles of the two proteins as regulators in acute inflammatory reaction. Inflammation 35: 409–419.CrossRefPubMed Koike, A., S. Arai, S. Yamada, A. Nagae, N. Saita, H. Itoh, S. Uemoto, M. Totani, and M. Ikemoto. 2012. Dynamic mobility of immunological cells expressing S100A8 and S100A9 in vivo: A variety of functional roles of the two proteins as regulators in acute inflammatory reaction. Inflammation 35: 409–419.CrossRefPubMed
34.
go back to reference Sunahori, K., M. Yamamura, J. Yamana, K. Takasugi, M. Kawashima, H. Yamamoto, W.J. Chazin, Y. Nakatani, S. Yui, and H. Makino. 2006. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Research & Therapy 8: 1–12.CrossRef Sunahori, K., M. Yamamura, J. Yamana, K. Takasugi, M. Kawashima, H. Yamamoto, W.J. Chazin, Y. Nakatani, S. Yui, and H. Makino. 2006. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Research & Therapy 8: 1–12.CrossRef
Metadata
Title
Establishment of S100A8 Transgenic Rats to Understand Innate Property of S100A8 and Its Immunological Role
Authors
Kohki Okada
Hiroshi Itoh
Yasuhiko Kamikubo
Souichi Adachi
Masaki Ikemoto
Publication date
01-02-2018
Publisher
Springer US
Published in
Inflammation / Issue 1/2018
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0664-8

Other articles of this Issue 1/2018

Inflammation 1/2018 Go to the issue